US 7294687
Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
granted A61KA61K31/724A61K38/10
Quick answer
US patent 7294687 (Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/724, A61K38/10, A61K47/6951, A61K9/0019